Who benefits from phase I studies?

Ann Oncol. 1990;1(3):164-5. doi: 10.1093/oxfordjournals.annonc.a057712.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Drug Evaluation* / methods
  • Ethics, Medical*
  • Humans
  • Neoplasms / drug therapy*